ConductScience.org, home

Paper39700441

Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now.

Shore N and 25 others. JCO Oncol Pract, 2025. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now. Papers, record 39700441. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39700441

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now.
PubMed
Journal
JCO Oncol Pract
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
2.53, provisional
iCite
Revised in PubMed
2026-09-24
PubMed

Authors26

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

See all 26 authorsDownload CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Genetic TestingMajor topic
Germ-Line MutationMajor topic
Prostatic NeoplasmsMajor topic
Standard of CareMajor topic
Humans
Male

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 CA008748NCI NIH HHSUnited StatesP30CA008748PubMed and NIHNIH RePORTER
R37 CA241486NCI NIH HHSUnited StatesR37CA241486PubMed and NIHNIH RePORTER

Download CSV of grants

References96

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135012874Helix: A Digital Tool to Address Provider Needs for Prostate Cancer Genetic Testing in Clinical Practice.Clin Genitourin Cancer2022https://conductscience.org/library/papers/35012874PubMed
230625039PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer.J Clin Oncol2019https://conductscience.org/library/papers/30625039PubMed
335930793Satisfaction With Clinician-Led Germline Genetic Counseling in Patients With Prostate Cancer.J Urol2022https://conductscience.org/library/papers/35930793PubMed
434711450Association of Inherited Mutations in DNA Repair Genes with Localized Prostate Cancer.Eur Urol2022https://conductscience.org/library/papers/34711450PubMed
537733366Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive Prostate Cancer.JAMA Oncol2023https://conductscience.org/library/papers/37733366PubMed
623569316Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.J Clin Oncol2013https://conductscience.org/library/papers/23569316PubMed
736600087Prostate cancer risk, screening and management in patients with germline BRCA1/2 mutations.Nat Rev Urol2023https://conductscience.org/library/papers/36600087PubMed
827989354Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death.Eur Urol2017https://conductscience.org/library/papers/27989354PubMed
926629066CHEK2 mutation and risk of prostate cancer: a systematic review and meta-analysis.Int J Clin Exp Med2015https://conductscience.org/library/papers/26629066PubMed
1022236224Germline mutations in HOXB13 and prostate-cancer risk.N Engl J Med2012https://conductscience.org/library/papers/22236224PubMed
1130730552Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines.JAMA Oncol2019https://conductscience.org/library/papers/30730552PubMed
1237276540Germline Genetic Testing After Cancer Diagnosis.JAMA2023https://conductscience.org/library/papers/37276540PubMed
1337958398Phase II Trial Evaluating Olaparib Maintenance in Patients with Metastatic Castration-Resistant Prostate Cancer Responsive or Stabilized on Docetaxel Treatment: SOGUG-IMANOL Study.Cancers (Basel)2023https://conductscience.org/library/papers/37958398PubMed
1433146377Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast Cancer.J Natl Cancer Inst2021https://conductscience.org/library/papers/33146377PubMed
1531629432Germline testing for prostate cancer prognosis: implications for active surveillance.Can J Urol2019https://conductscience.org/library/papers/31629432PubMed
1636509074NCCN GuidelinesĀ® Insights: Prostate Cancer, Version 1.2023.J Natl Compr Canc Netw2022https://conductscience.org/library/papers/36509074PubMed
1736103646Addition of Germline Testing to Tumor-Only Sequencing Improves Detection of Pathogenic Germline Variants in Men With Advanced Prostate Cancer.JCO Precis Oncol2022https://conductscience.org/library/papers/36103646PubMed
1831337882Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database.Genet Med2020https://conductscience.org/library/papers/31337882PubMed
1934006922PALB2 mutations and prostate cancer risk and survival.Br J Cancer2021https://conductscience.org/library/papers/34006922PubMed
2032986533Practical Considerations and Challenges for Germline Genetic Testing in Patients With Prostate Cancer: Recommendations From the Germline Genetics Working Group of the PCCTC.JCO Oncol Pract2020https://conductscience.org/library/papers/32986533PubMed

See all 96 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
42842178Bridging the implementation gap in hereditary cancer care for prostate cancer: a narrative review and Japanese environmental scan.Int J Clin Oncol2026https://conductscience.org/library/papers/42842178PubMed
42569313Recruitment strategies in the PROMISE Registry: Evaluating institutional outreach, direct-to-patient marketing, and community engagement approaches in a decentralized germline genetic registry.Contemp Clin Trials Commun2026https://conductscience.org/library/papers/42569313PubMed
42502690Identifying and characterizing the germinal genetic landscape of men with prostate cancer: A real-life, retrospective, multicenter study.Genet Med Open2026https://conductscience.org/library/papers/42502690PubMed
42422224Universal Germline Genetic Testing in a Precision Oncology and Rare Cancer Clinic: Implementation and Outcomes.JCO Oncol Adv2026https://conductscience.org/library/papers/42422224PubMed
41579216Delphi panel consensus on genetic testing for prostate cancer in Australia: Whom to test and how?Fam Cancer2026https://conductscience.org/library/papers/41579216PubMed
41568010Universal vs. ASCO guidelines-based germline genetic testing for newly diagnosed breast cancer patients in resource-restricted settings.Oncol Rev2025https://conductscience.org/library/papers/41568010PubMed
41330714Homologous recombination repair genetic testing variables and diagnostic paths for prostate cancer patients: a multicenter cohort study.Oncologist2025https://conductscience.org/library/papers/41330714PubMed
41294857Precision Oncology: Current Landscape, Emerging Trends, Challenges, and Future Perspectives.Cells2025https://conductscience.org/library/papers/41294857PubMed
41168197Whole genome sequencing-based analysis of genetic predisposition to adult glioblastoma.NPJ Genom Med2025https://conductscience.org/library/papers/41168197PubMed
40906325A phase 1b/2 study of intermittent talazoparib plus temozolomide in patients with metastatic castration-resistant prostate cancer and no mutations in DNA damage response genes.Invest New Drugs2025https://conductscience.org/library/papers/40906325PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39700441

GET https://conductscience.org/api/papers/v1/39700441/authors?page=2